Clinical Trial Update: Study of Oral MRT-2359 in Selected Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 trial evaluating MRT-2359 in multiple cancer indications; trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Diffuse Large B-cell Lymphoma
• Myc-amplified Solid Tumors
• Neuroendocrine Carcinoma
• Non-small Cell Lung Cancer
• Prostate Cancer
• Small Cell Lung Cancer

Drugs mentioned

• MRT-2359

Snippet

Sponsor: Monte Rosa Therapeutics, Inc | Conditions: NSCLC, SCLC | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING